Meshalkin Research Institute of Pathology of Circulation: Atrial Fibrillation trials
The registry lists 30 Atrial Fibrillation studies with Meshalkin Research Institute of Pathology of Circulation as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 17Phase 3 9No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVRNot yet recruitingNCT07434661Phase 3
- Pulmonary Artery Denervation in Patients With Atrial Fibrillation and Group 2 of Pulmonary HypertensionRecruitingNCT05856461Not applicable
- TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac SurgeryStatus unknownNCT03539354Not applicable
- Epicardial Fat Pads Ablation During Coronary SurgeryStatus unknownNCT02984371Phase 2
- The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial FibrillationStatus unknownNCT02982434Phase 2
- Comparison of the Ganglionated Plexi Activity in Patients With Different Forms of Atrial Fibrillation Guided by SUMO TechnologyStatus unknownNCT02914860Phase 1/2
- Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac SurgeryStatus unknownNCT02617069Phase 2/3
- Effect of Left Atrial Appendage Excision on Procedure Outcome in Patients With Persistent and Long-standing Persistent Atrial Fibrillation Undergoing Surgical AblationStatus unknownNCT02562391Phase 2
- Atrial Ganglionated Plexi Ablation Guided by the SUMO Technology With and Without Conventional Pulmonary Vein Isolation in Patients With Persistent AFStatus unknownNCT02492256Phase 2
- Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium EnlargementCompletedNCT02474108Not applicable
- The Assessment of Progression of Paroxysmal AF After CABGStatus unknownNCT02246803Phase 3
- Surgical Ablation of Long-standing Persistent AF During CABGStatus unknownNCT02246790Phase 3
- Ablation and Left Atrium Reduction During Mitral Valve Surgery for Atrial FibrillationCompletedNCT02047279Not applicable
- Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial FibrillationStatus unknownNCT02008448Phase 2
- Botulinum Toxin Injection Prevent Paroxysmal Atrial FibrillationStatus unknownNCT02002988Phase 1
- Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial FibrillationStatus unknownNCT02002923Phase 2
- Comparison of Redo PVI With vs. Without Renal Denervation for Recurrent AF After Initial PVIStatus unknownNCT01959997Phase 2
- Ganglionated Plexi Ablation vs Renal Denervation in Patients Undergoing Pulmonary Vein IsolationCompletedNCT01898910Phase 2
- Combined Treatment of Arterial Hypertension and Atrial FibrillationCompletedNCT01897545Phase 2
- Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial FibrillationCompletedNCT01873352Phase 3
- Botulinum Toxin Injection in Epicardial Fat Pads To Treat Atrial Fibrillation After Cardiac SurgeryCompletedNCT01842529Phase 2
- Thoracoscopic Versus Endocardial Ablation in Patient With Paroxysmal AF After Failed Initial Endocardial AblationCompletedNCT01794416Phase 2
- A Comparison of the Drug Therapy Versus Re-AblationCompletedNCT01709682Phase 2
- Ganglionated Plexi Ablation Combined With Pulmonary Vein IsolationCompletedNCT01703247Phase 2
- Left Atrial Appendage (LAA) Occluders After Catheter Ablation of Atrial FibrillationCompletedNCT01695824Phase 2
- Cryoballoon Ablation of Pulmonary Veins After Failed RF Ablation in Patients With Paroxysmal AFCompletedNCT01611701Phase 3
- Rate Ventricular Control Therapy in Patients With Permanent Atrial FibrillationStatus unknownNCT01444573Phase 3
- Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass GraftingTerminatedNCT01175330Phase 3
- "UNMASKING Study" For Atrial Fibrillation Recurrences Typing in Early Postoperative PeriodCompletedNCT01164319Phase 3
- Combined Treatment of Resistant Hypertension and Atrial FibrillationCompletedNCT01117025Phase 2